SYK: STRYKER CORP Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 58 hrs, 53 mins

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

STRYKER CORP

SYK

Stock price

62.50 -0.06 -0.10%

as of 01:03 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Extended Hours

— — —

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts

Insightful information about industries, companies, and the people who lead them.

Learn More.

2007 Sales	2007 Sales Growth	2007 Net Income	2007 Employees
$6,000,500,000	11.0%	$1,017,400,000	16,026

Key Executives: SYK

Name	Title	Officer Since
Stephen P. MacMillan	CEO	1/1/05
Dean H. Bergy	CFO	-
Curtis E. Hall	General Counsel	-
James E. Kemler	Vice President	-
Stephen Si Johnson	Vice President	-
Thomas R. Winkel	Vice President	-
Luciano Cattani	Executive VP, Divisional	-
William U. Parfet	Director	1/1/93

View All Key Executives

Luciano Cattani, who currently serves as Vice President; Group President, International of the Company, commencing January 1, 2008, Mr. Cattani's role and responsibilities with the Company will be reduced, and he will no longer serve as Vice President; Group President, International of the Company. Commencing on January 1, 2008, Mr. Cattani will serve as Executive Vice President, International Public Affairs of the Company. He will also continue... View Full Profile

Luciano Cattani

Stephen P. MacMillan, President and Chief Executive Officer of the Company since January 2005; and President and Chief Operating Officer of the Company from June 2003 through December 2004. Prior to joining Stryker in June 2003, he was Sector Vice President, Global Specialty Operations of Pharmacia Corporation from December 1999. was President of Johnson & Johnson - Merck Consumer Pharmaceuticals from January to December 1999 and held other... View Full Profile

Stephen P. MacMillan

Curtis E. Hall, age 51, was appointed Vice President and General Counsel of the Company in June, 2004. He had previously been General Counsel for the Company since 1994. Prior to joining the Company, he was a partner in the Michigan law firm of Miller, Canfield, Paddock and Stone, an Assistant United States Attorney in Washington, D.C. and an Assistant District Attorney in New York City.... View Full Profile

Curtis E. Hall

William U. Parfet, Chairman and Chief Executive Officer of MPI Research, Inc., a drug safety and pharmaceutical development company, since 1999. Also a director of Monsanto Company, a provider of agricultural products that improve farm productivity, and Taubman Centers, Inc., a real estate development company.... View Full Profile

William U. Parfet

John W. Brown, Chairman of the Board of the Company, since 1981; President and Chief Executive Officer of the Company from February 1977 to June 2003; and Chief Executive Officer of the Company from June 2003 through December 2004. Also a director of St. Jude Medical, Inc., a medical device company, Gen-Probe, Inc., a manufacturer of nucleic tests to diagnose human diseases and screen human blood, and the American Business Conference, an... View Full Profile

John W. Brown

Louise L. Francesconi, President of Raytheon Missile Systems, a Raytheon Company business, which she has led since 1996. Also a member of the Tucson Medical Center HealthCare board of trustees.... View Full Profile

Louise L. Francesconi

Dean H. Bergy, age 48, was appointed Vice President and Chief Financial Officer in January 2003 and was the Vice President, Finance of the Company since October 1998. He had previously been Vice President, Finance of the Stryker Medical division since October 1996 and Controller of the Company from June 1994. Prior to joining the Company in June 1994, he was a Senior Manager with Ernst & Young LLP.... View Full Profile

Dean H. Bergy

Donald M. Engelman, Ph.D., Eugene Higgins Professor of Molecular Biophysics and Biochemistry, Yale University, since 1979, with assignment to Yale College, the Graduate School and the Medical School. Also a trustee of Reed College and a member of the National Academy of Science since 1997.... View Full Profile

Donald M. Engelman, Ph.D.

Howard E. Cox, Jr., Partner of Greylock and its affiliated venture capital partnerships since 1971.... View Full Profile

Howard E. Cox, Jr.

James E. Kemler, age 50, was appointed Vice President of the Company in August 2001 and was appointed Group President, Stryker Biotech, Osteosynthesis and Development in January 2008. He had previously been President of Stryker Biotech since 1996 and General Manager of Stryker Biotech since October 1995. Prior to joining the Company in October 1995, he spent 11 years with Baxter International Inc. in a variety of marketing, manufacturing and... View Full Profile

James E. Kemler

James E. Kemler, age 50, was appointed Vice President of the Company in August 2001 and was appointed Group President, Stryker Biotech, Osteosynthesis and Development in January 2008. He had previously been President of Stryker Biotech since 1996 and General Manager of Stryker Biotech since October 1995. Prior to joining the Company in October 1995, he spent 11 years with Baxter International Inc. in a variety of marketing, manufacturing and... View Full Profile

Jerome H. Grossman, M.D.

Ronda E. Stryker, Granddaughter of the founder of the Company and daughter of a former President of the Company. Also Vice Chair and a director of Greenleaf Trust, a bank, Vice Chair and trustee of Spelman College, and a trustee of Kalamazoo College and the Kalamazoo Community Foundation.... View Full Profile

Ronda E. Stryker

Stephen Si Johnson, age 51, was appointed Vice President of the Company in February 2000 and was appointed Group President, MedSurg in September 1999. He had previously been President of Stryker Instruments since 1995. After joining the Company in 1980 he held various sales and marketing positions in the MedSurg Group and was appointed General Manager of Stryker Instruments in 1992 and Executive Vice President of Stryker Instruments in 1994.... View Full Profile

Stephen Si Johnson

Thomas R. Winkel, age 55, was appointed Vice President of the Company in December 1984 and was appointed Secretary of the Company in February 2005. He had previously been President of Stryker Americas/Middle East since March 1992 and Vice President, Administration since June 1987. Since joining the Company in October 1978, he has held various other positions, including Assistant Controller and Controller.... View Full Profile

Thomas R. Winkel

Michael W. Rude, age 46, was appointed Vice President, Human Resources of the Company in July 2000. Prior to joining the Company, he served as Vice President of Human Resources for the SCIMED Division of Boston Scientific Corporation. Prior to that he held various positions as Vice President, Human Resources within The Dun & Bradstreet Corporation and spent eight years in various Human Resources positions at Baxter International, Inc.... View Full Profile

Michael W. Rude

Top Competitors: SYK

View Detailed Competitors Chart

Insider Trends: SYK
Sentiment for SYK is POSITIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: SYK

Date	Name	Shares	Transaction Type	Market Value
07/03/08	COX HOWARD ELLIS JR	20,000	Exercise of Stock Options	$168,400.00
05/27/08	STRYKER JON L	7,000	Sale	$436,365.30
05/20/08	PARFET WILLIAM U	20,000	Exercise of Stock Options	$168,400.00

View All Insider Activity

Ownership Breakdown : SYK

Large Block Holder Type	Number
Institutions	931.00
Mutual Fund	1,141.00
Other Major	16.00

Full Details

Indices : SYK

Symbol	Name	Last Trade	Change
$RUI.X	Russell 1000 Index	690.92	-0.56 -0.08%
$INX	S&P 500 Index	1,262.90	1.38 0.11%
—	Fortune 500 Industrial Index	—	——%

View all Indices that include SYK

Short Interest Volume: SYK

Data as of 6/10/08

Current Short Interest Shares	1.10 B
Current Short Interest Ratio	7.20
Float	390.30 M

Short Interest as % of Float	2.30
Average Daily Volume	1.20 M
Outstanding Shares	411.79 M

Full Details

SEC Filings: SYK

Accepted Date	Description
07/03/2008	SEC Filing: Insider Buy/Sell
06/02/2008	SEC Filing: Insider Buy/Sell
05/05/2008	SEC Filing: Quarterly Financials

View all SEC Filings

Get Profile Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

STRYKER CORP

SYK

Stock price

62.50 -0.06 -0.10%

as of 01:03 PM EDT on 07/03/2008 in USD (NYSE Delay: 20 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts

Quote Search Search the Web Search

More in Money & Finance
- Money
- Earnings
- Tech News
- Stock Screener
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Reports
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Online Tax Filing
- Tax Advice
- Tax Basics
- Tax Forms
- Audit
- Tax Credit
- Tax Deduction
- AMT
- Small Business
- BloggingStocks
- BloggingBuyouts
- Luxist
- TUAW
- DJIA
- Dow Jones Industrial Average
More Stock Research
Notices and Terms: Confirm all data with your broker before trading.

Quote data provided by Interactive Data. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Financial.

The STRYKER CORP profile at AOL Money & Finance provides you with all the syk investing information you need. Reference AOL Money & Finance before you make your next investment!

© 2008 AOL LLC. All Rights Reserved.

AOL@Money © 2008 AOL LLC. All Rights Reserved.

Live Updates:

Ticker

Dynamic view of the market

STRYKER CORP

SYK

Stock price

Extended Hours

Analyst Consensus

STRYKER CORP Profile

Key Executives: SYK

Top Competitors: SYK

Insider Trends: SYK

Insider Transactions: SYK

Ownership Breakdown : SYK

Indices : SYK

Short Interest Volume: SYK

SEC Filings: SYK

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials